Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry

被引：0

作者：

Papp, Kim ^{[1
]}

Gooderham, Melinda ^{[2
]}

Haydey, Richard ^{[3
]}

Alam, Maryam Shayesteh ^{[3
]}

Brassard, Danielle ^{[4
]}

Delorme, Isabelle ^{[4
]}

Loo, Wei-Jing ^{[4
]}

Rao, Jaggi ^{[4
]}

Wasel, Norman ^{[4
]}

Vieira, Antonio ^{[4
]}

Rihakova, Lenka ^{[4
]}

机构：

[1] Clin Res & Prob Med Res, Waterloo, ON, Canada

[2] SKiN Ctr Dermatol, Peterborough, ON, Canada

[3] SimcoDerm Med & Surg Dermatol Ctr, Barrie, ON, Canada

[4] Novartis Pharmaceut Canada, Dorval, PQ, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

18257

引用

页码：AB95 / AB95

页数：1